The Sanger sequencing market was valued at USD 2.9 Billion in 2023 and is projected to reach USD 12.35 Billion by 2032, growing at a compound annual growth rate (CAGR) of 18.63% from 2024 to 2032.
454 Life Sciences Corporation has announced the launch of the new GS FLX Titanium series reagents and software that are transforming the life science’s industry. According to Company, the new reagent ...
As an important supplier to the Wellcome Trust Sanger Institute, New England Biolabs is pleased to announce that the Sanger Institute will use New England Biolabs as one of its suppliers for ...
NUMEROUS papers have been published concerning the identification and determination of amino-acids by the dinitrophenylation method introduced by Sanger 1. We are not aware, however, of any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results